10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001651308-23-000068`
Period End Date	20230331
Filing Date	20230504
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	bgne-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 40 Cash Flow Statement 79 Stockholders Equity 21 Comprehensive Income 8

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.87B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.54B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.35B	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.36B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$159.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$196.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.36B	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$665.25M	USD	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$294.06M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$173.17M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$309.63M	USD	Point-in-time
Inventories	`InventoryNet`	$297.00M	USD	Point-in-time
Inventories	`InventoryNet`	$282.35M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$216.55M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$264.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.70B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.21B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.96M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.96M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.28M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$845.95M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$925.40M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$109.96M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$108.99M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$40.62M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$39.73M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$173.37M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$170.41M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.25B	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.17B	USD	Point-in-time
Total assets	`Assets`	$6.38B	USD	Point-in-time
Total assets	`Assets`	$5.96B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$241.36M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$294.78M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$417.92M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$467.35M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$213.86M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$185.48M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$33.93M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$25.19M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$24.04M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$24.55M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$69.51M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$114.33M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.27B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$281.81M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$328.97M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	1.94B	CNY	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.25B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.47B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.42B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.44B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$206.30M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$209.15M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$37.34M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$42.03M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$32.54M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$34.52M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$16.06M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$16.00M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$207.05M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$179.62M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$46.09M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$45.62M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$544.92M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$527.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.80B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.00B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,362,652,101 and 1,356,140,180 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$136.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,362,652,101 and 1,356,140,180 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$135.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.64B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.54B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-59.01M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-77.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.43B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.08B	USD	Point-in-time
Total equity	`StockholdersEquity`	$4.16B	USD	Point-in-time
Total equity	`StockholdersEquity`	$6.13B	USD	Point-in-time
Total equity	`StockholdersEquity`	$4.38B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.77B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.96B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$6.38B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$306.63M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$447.80M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$65.24M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$81.79M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$389.92M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$408.58M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$294.57M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$328.50M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$187.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$749.91M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$819.06M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-443.29M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-371.26M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$10.07M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$16.02M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$11.97M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$18.30M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-421.25M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-336.94M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$13.95M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$11.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.26	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.33	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.33	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.26	USD	1 Quarter
Weighted-average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.33B	shares	1 Quarter
Weighted-average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.35B	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.35B	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-3.34	USD	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-4.25	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-3.34	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-4.25	USD	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	104.17M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.46M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.46M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	104.17M	shares	1 Quarter

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$20.01M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$16.60M	USD	1 Quarter
Share-based compensation expenses	`ShareBasedCompensation`	$65.56M	USD	1 Quarter
Share-based compensation expenses	`ShareBasedCompensation`	$75.32M	USD	1 Quarter
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-16.97M	USD	1 Quarter
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-169.00K	USD	1 Quarter
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-17.40M	USD	1 Quarter
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-21.82M	USD	1 Quarter
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$50.00K	USD	1 Quarter
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$36.00K	USD	1 Quarter
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$575.00K	USD	1 Quarter
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$3.54M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$136.49M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-292.55M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$13.03M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$3.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$50.41M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$16.94M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-35.02M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-22.59M	USD	1 Quarter
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-78.75M	USD	1 Quarter
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-38.68M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-39.68M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-33.07M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.43M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$197.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-563.78M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-236.56M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.13M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$125.58M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$1.06M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$504.00K	USD	1 Quarter
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$331.03M	USD	1 Quarter
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$376.96M	USD	1 Quarter
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	-	USD	1 Quarter
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$75.00M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$9.25M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$241.06M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$210.39M	USD	1 Quarter
Repayment of long-term loan	`RepaymentsOfLongTermDebt`	$1.46M	USD	1 Quarter
Repayment of long-term loan	`RepaymentsOfLongTermDebt`	-	USD	1 Quarter
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	-	USD	1 Quarter
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$50.00M	USD	1 Quarter
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$73.15M	USD	1 Quarter
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$50.00M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$31.59M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$11.88M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.87M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.27M	USD	1 Quarter
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.31M	USD	1 Quarter
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.00M	USD	1 Quarter
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-331.27M	USD	1 Quarter
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.44M	USD	1 Quarter
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.35B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.54B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.88B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.35B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.54B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.88B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.87B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.54B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.35B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$159.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$196.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.96M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.96M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.28M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$7.62M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$736.00K	USD	1 Quarter
Interest paid	`InterestPaidNet`	$6.62M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$5.02M	USD	1 Quarter
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$62.74M	USD	1 Quarter
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$64.01M	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquity`	$4.16B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$6.13B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$4.38B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$5.77B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Cost from issuance of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	-	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$11.88M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$28.66M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$75.32M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$65.56M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-496.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$18.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Balance at the end of period	`StockholdersEquity`	$4.16B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$6.13B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$4.38B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$5.77B	USD	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time

Comprehensive Income 8 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$9.37M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$13.35M	USD	1 Quarter
Unrealized holding income (loss), net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-9.87M	USD	1 Quarter
Unrealized holding income (loss), net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$5.06M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-330.03M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-435.69M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.